Novo Nordisk says it will cut the price of Wegovy. This comes after a similar move by Zepound-maker Eli Lilly.
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.
Eli Lilly and Company (NYSE:LLY) and EVA Pharma announced today that the companies have entered into an agreement to expand access to baricitinib to an estimated ...
Eli Lilly and Company (NYSE:LLY) and EVA Pharma announced today that the companies have entered into an agreement to expand access to baricitinib to an estimated 20,000 people in... Tuesday, Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results